Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

KX2-361

Copy Product Info
🥰Excellent
Catalog No. T9411Cas No. 897016-26-1

KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

KX2-361

KX2-361

Copy Product Info
🥰Excellent
Purity: 99.68%
Catalog No. T9411Cas No. 897016-26-1
KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$74In StockIn Stock
5 mg$173In StockIn Stock
10 mg$248In StockIn Stock
25 mg$407In StockIn Stock
50 mg$572In StockIn Stock
100 mg$768In StockIn Stock
200 mg$987In StockIn Stock
1 mL x 10 mM (in DMSO)$191In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.68%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

KX2-361 AI Summary
KX2-361 exhibits various bioactivities based on the provided data. It has moderate oral bioavailability in mice at 40.0% and shows antitumor activity against mouse GL261 cells, achieving a 30% activity level at a dosage of 30 mg/kg. The compound demonstrates potent antiproliferative activity against a range of human cancer cell lines, with GI50 values ranging from 2.9 nM to 76.0 nM. Additionally, it inhibits Src kinase activity, with an IC50 value of 67000.0 nM in the general assay and a significantly lower IC50 value of 60.0 nM in a specific assay on mouse GL261 cells..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
Chemical Properties
Molecular Weight405.46
FormulaC24H24FN3O2
Cas No.897016-26-1
SmilesC(C(NCC1=CC(F)=CC=C1)=O)C=2C=CC(C3=CC=C(C=C3)N4CCOCC4)=CN2
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 8.75 mg/mL (21.58 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4663 mL12.3317 mL24.6633 mL123.3167 mL
5 mM0.4933 mL2.4663 mL4.9327 mL24.6633 mL
10 mM0.2466 mL1.2332 mL2.4663 mL12.3317 mL
20 mM0.1233 mL0.6166 mL1.2332 mL6.1658 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KX2-361 | purchase KX2-361 | KX2-361 cost | order KX2-361 | KX2-361 chemical structure | KX2-361 formula | KX2-361 molecular weight